Qiagen flags press release on molecular testing solutions for rising US Cyclospora outbreak

PUBT · 1d ago
Qiagen flags press release on molecular testing solutions for rising US Cyclospora outbreak
  • Qiagen published a press release highlighting molecular testing products supporting the U.S. response to a growing Cyclospora outbreak.
  • Release cites more than 1,600 confirmed U.S. cyclosporiasis cases since May 2026, with about 7,000 potential cases under investigation.
  • Qiagen flagged its FDA-cleared QIAstat-Dx Gastrointestinal Panel 2, which detects Cyclospora in about an hour as part of a 16-target menu.
  • It also pointed to QIAcuity digital PCR and QIAseq NGS tools for research and public health investigations.
  • More information is available at www.qiagen.com.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qiagen NV published the original content used to generate this news brief on July 15, 2026, and is solely responsible for the information contained therein.